• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

专家对肌醇治疗多囊卵巢综合征和非胰岛素依赖型糖尿病的看法:对人类生殖的进一步帮助及其他。

Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond.

机构信息

Department of Obstetrics and Gynecology and Pediatrics, University of Modena and Reggio Emilia, Modena, Italy.

Oncological Endocrinology Unit, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.

出版信息

Expert Opin Drug Metab Toxicol. 2020 Mar;16(3):255-274. doi: 10.1080/17425255.2020.1737675. Epub 2020 Mar 19.

DOI:10.1080/17425255.2020.1737675
PMID:32129111
Abstract

: This Experts' opinion provides an updated scientific support to gynecologists, obstetricians, endocrinologists, nutritionists, neurologists and general practitioners on the use of Inositols in the therapy of Polycystic Ovary Syndrome (PCOS) and non-insulin dependent (type 2) diabetes mellitus (NIDDM).: This paper summarizes the physiology of Myo-Inositol (MI) and D-Chiro-Inositol (DCI), two important molecules present in human organisms, and their therapeutic role, also for treating infertility. Some deep differences between the physiological functions of MI and DCI, as well as their safety and intestinal absorption are discussed. Updates include new evidence on the efficacy exerted in PCOS by the 40:1 MI/DCI ratio, and the innovative approach based on alpha-lactalbumin to overcome the decreased therapeutic efficacy of Inositols in some patients.: The evidence suggests that MI, alone or with DCI in the 40:1 ratio, offers a promising treatment for PCOS and NIDDM. However, additional studies need to evaluate some still unresolved issues, such as the best MI/DCI ratio for treating NIDDM, the potential cost-effectiveness of reduced gonadotropins administration in IVF due to MI treatment, or the benefit of MI supplementation in ovulation induction with clomiphene citrate in PCOS patients.

摘要

这一专家意见为妇科医生、产科医生、内分泌学家、营养师、神经学家和全科医生提供了关于肌醇(MI)和 D-手性肌醇(DCI)在多囊卵巢综合征(PCOS)和非胰岛素依赖型(2 型)糖尿病(NIDDM)治疗中的应用的最新科学依据。本文总结了 MI 和 DCI 的生理学,这两种物质是人体中两种重要的分子,具有治疗作用,也可用于治疗不孕。还讨论了 MI 和 DCI 之间在生理功能上的一些深刻差异,以及它们的安全性和肠道吸收。更新内容包括关于 MI/DCI 比例为 40:1 在 PCOS 中发挥的疗效的新证据,以及基于α-乳白蛋白的创新方法,以克服某些患者中肌醇治疗效果降低的问题。有证据表明,MI 单独使用或与 40:1 比例的 DCI 联合使用,为 PCOS 和 NIDDM 提供了一种有前途的治疗方法。然而,仍需要进一步研究来评估一些尚未解决的问题,例如治疗 NIDDM 的最佳 MI/DCI 比例、由于 MI 治疗而减少 IVF 中促性腺激素给药的潜在成本效益,或在 PCOS 患者中使用枸橼酸氯米酚诱导排卵时补充 MI 的益处。

相似文献

1
Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond.专家对肌醇治疗多囊卵巢综合征和非胰岛素依赖型糖尿病的看法:对人类生殖的进一步帮助及其他。
Expert Opin Drug Metab Toxicol. 2020 Mar;16(3):255-274. doi: 10.1080/17425255.2020.1737675. Epub 2020 Mar 19.
2
Inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: now and the future.肌醇在治疗多囊卵巢综合征和非胰岛素依赖型糖尿病中的应用:现状与未来。
Expert Opin Drug Metab Toxicol. 2024 Jan-Feb;20(1-2):61-72. doi: 10.1080/17425255.2024.2306851. Epub 2024 Jan 22.
3
Inositols in Polycystic Ovary Syndrome: An Overview on the Advances.多囊卵巢综合征中的肌醇:研究进展概述。
Trends Endocrinol Metab. 2020 Jun;31(6):435-447. doi: 10.1016/j.tem.2020.02.002. Epub 2020 Mar 9.
4
Inositol for subfertile women with polycystic ovary syndrome.多囊卵巢综合征不孕女性使用肌醇的情况。
Cochrane Database Syst Rev. 2018 Dec 20;12(12):CD012378. doi: 10.1002/14651858.CD012378.pub2.
5
The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.与单独补充肌醇相比,肌醇和 D-手性肌醇联合治疗可降低 PCOS 超重患者代谢性疾病的风险。
Eur Rev Med Pharmacol Sci. 2012 May;16(5):575-81.
6
Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.多囊卵巢综合征中的肌醇:基于病理生理学的方法恢复生育能力。
Trends Endocrinol Metab. 2018 Nov;29(11):768-780. doi: 10.1016/j.tem.2018.09.001. Epub 2018 Sep 27.
7
Reflections on inositol(s) for PCOS therapy: steps toward success.多囊卵巢综合征治疗中肌醇的思考:迈向成功的步骤
Gynecol Endocrinol. 2015 Jul;31(7):501-5. doi: 10.3109/09513590.2015.1054802. Epub 2015 Jul 15.
8
Inositols' Importance in the Improvement of the Endocrine-Metabolic Profile in PCOS.肌醇在多囊卵巢综合征患者内分泌代谢特征改善中的重要性。
Int J Mol Sci. 2019 Nov 18;20(22):5787. doi: 10.3390/ijms20225787.
9
Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS.妇产科领域肌醇与D-手性肌醇国际共识会议结果:代谢综合征与多囊卵巢综合征之间的联系
Eur J Obstet Gynecol Reprod Biol. 2015 Dec;195:72-76. doi: 10.1016/j.ejogrb.2015.09.024. Epub 2015 Oct 3.
10
Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.联合使用肌醇和D-手性肌醇(40:1)进行治疗,对恢复多囊卵巢综合征患者的卵巢功能和代谢平衡有效。
Gynecol Endocrinol. 2017 Jan;33(1):1-9. doi: 10.1080/09513590.2016.1247797. Epub 2016 Nov 29.

引用本文的文献

1
Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial.膳食肌醇补充对胰岛素抵抗和预防妊娠糖尿病的影响:一项开放标签、随机对照试验。
Arch Gynecol Obstet. 2024 Oct;310(4):1895-1903. doi: 10.1007/s00404-024-07618-8. Epub 2024 Aug 14.
2
<sc>d</sc>-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI).《临床实践中的 D-手性肌醇:基础与临床研究手性肌醇专家组(EGOI)的观点》。
Gynecol Obstet Invest. 2024;89(4):284-294. doi: 10.1159/000536081. Epub 2024 Feb 19.
3
D-Chiro-Inositol and Myo-Inositol Induce WAT/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2).
D-手性肌醇和肌醇诱导两种不同的人脂肪细胞模型(SGBS 和 LiSa-2)的白色脂肪/棕色脂肪转分化。
Int J Mol Sci. 2023 Apr 18;24(8):7421. doi: 10.3390/ijms24087421.
4
The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner's Results.多囊卵巢综合征高雄激素表型中肌醇的作用:重新解读拉纳的研究结果。
Int J Mol Sci. 2023 Mar 27;24(7):6296. doi: 10.3390/ijms24076296.
5
Correlations between parameters of glycaemic variability and foetal growth, neonatal hypoglycaemia and hyperbilirubinemia in women with gestational diabetes.妊娠期糖尿病患者血糖变异性参数与胎儿生长、新生儿低血糖和高胆红素血症的相关性。
PLoS One. 2023 Mar 9;18(3):e0282895. doi: 10.1371/journal.pone.0282895. eCollection 2023.
6
ANTI-THYROID ANTIBODIES AND THE GONADOTROPHINS PROFILE (LH/FSH) IN EUTHYROID POLYCYSTIC OVARIAN SYNDROME WOMEN.甲状腺功能正常的多囊卵巢综合征女性的抗甲状腺抗体与促性腺激素谱(促黄体生成素/促卵泡生成素)
Acta Endocrinol (Buchar). 2022 Jan-Mar;18(1):79-85. doi: 10.4183/aeb.2022.79.
7
Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.肌醇营养补充剂预防妊娠糖尿病:随机对照试验的系统评价和荟萃分析。
Nutrients. 2022 Jul 9;14(14):2831. doi: 10.3390/nu14142831.
8
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.多囊卵巢综合征心血管风险早期标志物的评估
touchREV Endocrinol. 2021 Apr;17(1):37-53. doi: 10.17925/EE.2021.17.1.37. Epub 2021 Apr 28.
9
Analyses of Antioxidative Properties of Selected Cyclitols and Their Mixtures with Flavanones and Glutathione.分析选定环糖醇及其与黄烷酮和谷胱甘肽混合物的抗氧化性能。
Molecules. 2021 Dec 28;27(1):158. doi: 10.3390/molecules27010158.
10
Inositols: From Established Knowledge to Novel Approaches.肌醇:从已有知识到新方法。
Int J Mol Sci. 2021 Sep 30;22(19):10575. doi: 10.3390/ijms221910575.